🇺🇸 FDA
Patent

US 8865771

Amides useful as inhibitors of voltage-gated sodium channels

granted A61PA61P13/02A61P19/02

Quick answer

US patent 8865771 (Amides useful as inhibitors of voltage-gated sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P13/02, A61P19/02, A61P25/02, A61P25/04